Own a part of our business. Capital at Risk.
View our pitch
Innovate UK awards Stablepharma a second grant to advance fridge-free vaccines
Wealth Briefing reports on new Advisory Board Members Joining Stablepharma Ltd
Stablepharma sign a second exclusive supply agreement to develop a fridge-free Tetanus vaccine
Lorena Carmona Rodriquez as Senior Scientist to specifically progress mRNA-LNP programme.
Martin Powell RIP 1956 – 2023
Richard Amaee joins the team to progress development of fridge-free Tetanus diphtheria vaccine (SPVX02)
Professor Saul Faust, Advisory Board Member of Stablepharma, receives OBE at Buckingham Palace
Mergermarket Interview with Stablepharma CEO on future IPO and Series B raise
Stablepharma closed Series A funding round of $6.4m to progress fridge-free vaccines and mRNA/LNP stabilisation technologies
Johnny Sutton joins the Stablepharma Ltd Board of Directors
Stablepharma sign exclusive supply agreement to produce the world’s first fridge-free Tetanus diphtheria vaccine
New Data demonstrates StablevaX™-Td Vaccine Stable after 12 months at +45°C